DAA1547 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 3 |
Molecular |
liver |
Mouse |
St3gal3 |
25.0% Increase Gene Expression Level |
|
DAA1529 |
trefoil factor 3, intestinal |
Molecular |
liver |
Mouse |
Tff3 |
97.0% Increase Gene Expression Level |
|
DAA1515 |
tripartite motif-containing 43A |
Molecular |
liver |
Mouse |
Trim43a |
5.0% Decrease Gene Expression Level |
|
DAA1060 |
Blood flow to liver decreases |
Physiological |
liver |
Human |
— |
— |
|
DAA637 |
Chronic liver disease and cirrhosis |
Pathological |
liver |
Human |
— |
SeriesMorbidity |
|
DAA638 |
Cholelithiasis and other disorders of gallbladders |
Pathological |
liver and biliary system |
Human |
— |
SeriesMorbidity |
|
DAA594 |
Cancer of liver and intrahepatic bile ducts |
Pathological |
liver |
Human |
— |
SeriesMorbidity |
|
DAA2590 |
Loss of liver regeneration with age |
Physiological |
liver |
Human |
— |
— |
|
DAA849 |
telomere shortening |
Molecular |
liver |
Human |
— |
— |
|
DAA1061 |
Variability in clearance of hepatically metabolized drugs |
Physiological |
liver |
Human |
— |
— |
|
DAA588 |
Viral hepatitis |
Pathological |
liver |
Human |
— |
SeriesMorbidity |
|